BC Environmental and Occupational Health Research Network

The field of cancer prevention research is rapidly advancing and evolving. To sustain the advancement of the field and the development of new thinking and strategies, younger investigators must be encouraged to pursue cancer prevention research, yet few vehicles exist to recognize their accomplishments or support their early research efforts.
This award was established and first given in 2008 to recognize the outstanding achievement of a junior faculty-level scientist, and to provide support for cancer prevention research of significant scientific merit in any discipline across the continuum of research.

The AACR Gertrude B. Elion Cancer Research Award is open to tenure-track scientists at the level of assistant professor, who completed postdoctoral studies or clinical fellowships no more than four years prior to the start of the grant term. It provides a one-year grant of $50,000 for salary and benefits, supplies, equipment, and limited travel for the grant recipient. Projects may focus on research in cancer etiology, diagnosis, treatment or prevention (basic, translational or clinical cancer research).
The recipient of the 2011 award must attend the AACR 102nd Annual Meeting 2011 to accept the award and attend the AACR 103rd Annual Meeting 2012 to give a presentation of his or her research in a minisymposium.

International research collaboration can successfully address the global health problem of cancer through access to unique populations and environments, shared resources, specialized expertise, new concepts and perspectives, innovative methodologies and/or emerging technologies. However, barriers to sustaining these collaborations exist, such as the lack of funding as well as the lack of sharing of knowledge about these important research partnerships.
This award will support highly meritorious research that is being conducted collaboratively by investigators in different countries around the world.

The Landon Foundation-AACR INNOVATOR Award for Research in Personalized Cancer Medicine represents a joint effort between the Landon Foundation and AACR to accelerate progress in the area of personalized medicine by providing support for physician-scientists who conduct meritorious studies that hold promise for near-patient benefit.
Such studies may include:
• Proof-of-concept studies in humans;
• Translational clinical trials that utilize science-based methodologies for patient selection;
• Multidisciplinary research that includes the incorporation of disciplines that are new to cancer research, i.e., the physical sciences, mathematics, etc.;
• Studies that molecularly target pathways;
• The identification of genes and genetic variations that play a role in cancer treatment responses; or
• Other innovative areas of cancer therapeutics.

The field of cancer prevention research is rapidly advancing and evolving. To sustain the advancement of the field and the development of new thinking and strategies, younger investigators must be encouraged to pursue cancer prevention research, yet few vehicles exist to recognize their accomplishments or support their early research efforts.
This Award was established and first given in 2008 to recognize the outstanding achievement of a junior faculty-level scientist, and to provide support for cancer prevention research of significant scientific merit in any discipline across the continuum of research.

Five-year $700,000 awards for physician-scientists bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, translational, or molecular, genetic, or pharmacological epidemiology research. Proposals in the area of epidemiology should contact BWF to determine their eligibility. Proposals in health services research or involving large-scale clinical trials are ineligible. Awards are made to degree granting institutions in the U.S. or Canada on behalf of the awardee.

A limited number of Travel Awards to senior level PhD or MD/PhD students are available. The purpose of this program is to defray the travel costs associated with making a scientific presentation at a conference, symposium or other appropriate professional gathering.

The Canadian Cancer Society Prevention Initiative – Junior Investigator Awards in Prevention Research are career development awards and are intended for candidates who are in the early stages of their independent research career.
Applications are invited from candidates:
• Already working in the field of cancer prevention, or
• Working in other disciplines who would like to transition into cancer prevention research, and/or increase the focus of cancer prevention in their current research program

JDRF fosters the development and productivity of the best and the brightest established independent researchers who will bridge the gap between the bench and bedside. The primary purpose of the Career Development Award is to attract qualified and promising scientists early in their faculty careers and to give them the opportunity to establish themselves in areas that reflect the JDRF research emphasis areas.

The CIHR Knowledge Translation Award honours and supports the exemplary knowledge translation efforts and activities of an exceptional individual, team or organization that has made an outstanding contribution to increasing the application of research findings, improving the health of Canadians, health services and products, or strengthening the health-care system. Nominated individuals, teams or organizations will be assessed on significant achievements in knowledge translation activities relevant to any area of health research (e.g., biomedical, clinical, health services and policy, and population and public health). The achievements of the individual, team or organization that is the recipient of the CIHR Knowledge Translation Award will be celebrated at the annual CIHR Awards Ceremony held in Ottawa each fall.

The Prostate Cancer Canada (PCC) is offering a limited number of Clinician-Scientist awards, which provide salary and research support for outstanding Clinician-Scientists initiating a career as independent investigators/junior faculty in prostate cancer research. These awards provide the opportunity for new faculty with 4 or fewer years of service to develop and demonstrate independence in initiating and conducting prostate cancer research.

The purpose of the Canadian Cancer Society Prevention Initiative – Prevention Translation Supplement Awards competition is to stimulate the translation of existing cancer research findings into cancer prevention by supporting pilot studies of interventions. Applications are invited from current CCSRI grant holders across all disciplines to submit pilot studies that will translate their research findings into identifying effective interventions that reduce the cancer incidence in the human population. Interventions to prevent cancer are defined as research to modify determinants of, and/or changes to, behaviours or exposures that affect cancer risk.

The NSERC John C. Polanyi Award was created to recognize and support a university researcher or team of researchers whose work has led to a recent outstanding Canadian advance in a field of the natural sciences or engineering.

The purpose of this award is to bring new, creative investigators into active research on the health effects of air pollution. It provides three years of funding for a small project relevant to HEI’s research interests to a new investigator with outstanding promise at the Assistant Professor or equivalent level.
LOI Deadline: February 10

This Award was established and first given in 2008 to recognize the outstanding achievement of a junior faculty-level scientist, and to provide support for cancer prevention research of significant scientific merit in any discipline across the continuum of research. A two-year grant of $100,000 ($50,000 per year) will be provided to the recipient’s institution to support direct research expenses; salary and benefits; and attendance at an AACR Annual Meeting, Cancer Prevention Conference, or other AACR meeting for the purpose of participating in scholarly exchange.

Eligible applicants must:
• Be enrolled in graduate studies in one of the eligible institutions at the time of submitting your application;
• Submit a position paper addressing the policy options or models for one of the following issues:
o Issue: Food and Wellness Connection: "Can we afford to eat the same way?"
o Issue: Sustainability: "Can we afford to produce our food the same way?"
o Issue: Viability: "Should government change the way it supports the agriculture sector?"

The Multiple Myeloma Research Foundation (MMRF) supports investigators with more than five years of experience in blood cancer research. The goal of this initiative is to accelerate the development of therapeutic approaches for myeloma and may include proposals in basic science, validation, or translation research.

Eligible applicants must:
• Be enrolled in graduate studies in one of the eligible institutions at the time of submitting your application;
• Submit a position paper addressing the policy options or models for one of the following issues:
Issue: Food and Wellness Connection: "Can we afford to eat the same way?"
Issue: Sustainability: "Can we afford to produce our food the same way?"
Issue: Viability: "Should government change the way it supports the agriculture sector?"

The Health Services Research Advancement Award (HSRA Award) recognizes any individual, team or organization that has contributed significantly to the advancement of health services research in Canada.